A 4-week, dose-ranging study comparing the efficacy, safety and tolerability of latanoprost 75, 100 and 125 μg/mL to latanoprost 50 μg/mL (xalatan) in the treatment of primary open-angle glaucoma and ocular hypertension

BACKGROUND: Several studies have investigated the effect of latanoprost on intraocular pressure (IOP). We compared the IOP-lowering effects of three higher concentrations of latanoprost with the commercially available concentration of 0.005% (50 μg/mL) in patients with primary open-angle glaucoma or...

Descripción completa

Detalles Bibliográficos
Autores principales: Eveleth, David, Starita, Carla, Tressler, Charles
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475103/
https://www.ncbi.nlm.nih.gov/pubmed/22607109
http://dx.doi.org/10.1186/1471-2415-12-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3475103/
https://www.ncbi.nlm.nih.gov/pubmed/22607109
http://dx.doi.org/10.1186/1471-2415-12-9

Ejemplares similares